Shiva Hashemizadeh
Overview
Explore the profile of Shiva Hashemizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alami K, Fathollahi Y, Hashemizadeh S, Mosleh M, Semnanian S, Mousavi S, et al.
Neuropharmacology
. 2024 Nov;
263:110211.
PMID: 39521039
Persistent effects of adolescent morphine exposure on neurobiological processes and behaviors in adulthood have been partially identified. Hypersensitivity following adolescent exposure to morphine is a complex and multifaceted phenomenon whose...
2.
Hashemizadeh S, Alaee E, Aghajani N, Azizi H, Semnanian S
Biomed Pharmacother
. 2024 Nov;
181:117639.
PMID: 39520913
Opioid addiction is known as a chronic relapsing disorder associated with long-lasting molecular and cellular neuroadaptations that lead to compulsive behavior. Current pharmacotherapies target the modulation of mu-opioid receptors (MOR);...
3.
Eskandari S, Rezayof A, Asghari S, Hashemizadeh S
Neuropeptides
. 2023 Jun;
101:102356.
PMID: 37390744
Neurodegenerative diseases, including Alzheimer̕ s disease (AD), Parkinson̕ s disease (PD), Huntington̕ s disease (HD), and Amyotrophic Lateral Sclerosis (ALS) require special attention to find new potential treatment methods. This...
4.
Hashemizadeh S, Hosseindoost S, Omidi A, Aminianfar H, Ebrahimi-Barough S, Ai J, et al.
Front Cell Neurosci
. 2022 Dec;
16:993019.
PMID: 36505513
Bone-marrow mesenchymal stem cells (BM-MSCs) have not yet proven any significant therapeutic efficacy in spinal cord injury (SCI) clinical trials, due to the hostile microenvironment of the injured spinal cord...
5.
Hashemizadeh S, Gharaylou Z, Hosseindoost S, Sardari M, Omidi A, Ravandi H, et al.
Front Pharmacol
. 2022 Nov;
13:932487.
PMID: 36339604
Ion disturbances are among the most remarkable deficits in spinal cord injury (SCI). GABA is an integral part of neural interaction. Action of the GABA receptor depends on the amount...
6.
Mohaghghegh H, Ananloo E, Hadjighasem M, Karimipour M, Hashemizadeh S, Abhari S
J Mol Neurosci
. 2022 May;
72(8):1670-1681.
PMID: 35624355
Schizophrenia (SCZ) is a debilitating, destructive, and chronic mental disorder and affects approximately one percent of the human population. Diagnosis in psychiatry is based on the patient's descriptions of his/her...
7.
Hashemizadeh S, Pourkhodadad S, Hosseindoost S, Pejman S, Kamarehei M, Badripour A, et al.
Neuropeptides
. 2022 Feb;
92:102228.
PMID: 35101843
Damage to the spinal cord triggers a local complex inflammatory reaction that results in irreversible impairments or complete loss of motor function. The evidence suggested that inhibiting the pro-inflammatory macrophage/microglia...
8.
Hosseindoost S, Hashemizadeh S, Gharaylou Z, Dehpour A, Javadi S, Arjmand B, et al.
J Mol Neurosci
. 2020 Jun;
70(10):1451-1460.
PMID: 32506304
Glioblastoma multiforme (GBM) is described as an invasive astrocytic tumor in adults. Despite current standard treatment approaches, the outcome of GBM remains unfavorable. The downregulation of connexin 43 (Cx43) expression...
9.
Fakhraei N, Javadian N, Rahimian R, Nili F, Rahimi N, Hashemizadeh S, et al.
Inflammopharmacology
. 2018 Oct;
26(6):1399-1413.
PMID: 30318564
Purpose: There are several lines of evidence on the protective roles of opioids in gastrointestinal inflammatory conditions. This study aims to distinguish the central and peripheral roles of methadone, a...
10.
Valizadeh-Arshad Z, Shahbazi E, Hashemizadeh S, Moradmand A, Jangkhah M, Kiani S
Cell J
. 2017 Nov;
19(4):545-551.
PMID: 29105388
Objectives: Motor neuron differentiation from human embryonic stem cells (hESCs) is a goal of regenerative medicine to provide cell therapy as treatments for diseases that damage motor neurons. Most protocols...